本文へスキップ

相互作用

Lasmiditan + Rifaximin

重症度: 中等度

Lasmiditan and Rifaximin: moderate interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Lasmiditan inhibits intestinal P-glycoprotein and may increase absorption of P-gp substrates. Rifaximin is a P-gp substrate with low normal absorption, so systemic exposure can rise, particularly with hepatic impairment. The clinical significance with usual doses is uncertain.

この相互作用をわかりやすく説明すると

Lasmiditan and Rifaximin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lasmiditan belongs to Central Nervous System; Rifaximin belongs to Anti Bacterial.

エビデンスレベル: Low

なぜ起こるのか

Lasmiditan inhibits P-glycoprotein efflux, raising systemic exposure to rifaximin.

対処法

Monitor for rifaximin adverse effects, particularly in patients with severe hepatic impairment. Consider avoiding lasmiditan for a patient on long-term rifaximin with advanced liver disease.

薬剤師に尋ねること

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、LasmiditanとRifaximinの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を7日間無料でお試し。カード登録不要。

よくある質問

Can I take Lasmiditan with Rifaximin?

MediHelp rates the interaction as moderate. Lasmiditan and Rifaximin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lasmiditan inhibits intestinal P-glycoprotein and may increase absorption of P-gp substrates. Rifaximin is a P-gp substrate with low normal absorption, so systemic exposure can rise, particularly with hepatic impairment. The clinical significance with usual doses is uncertain.

How serious is the interaction between Lasmiditan and Rifaximin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for rifaximin adverse effects, particularly in patients with severe hepatic impairment. Consider avoiding lasmiditan for a patient on long-term rifaximin with advanced liver disease.

What other medicines interact with Rifaximin?

MediHelp also lists interactions of Rifaximin with, for example, Cholera vaccine, Microbiota, Amiodarone. The full list is on the Rifaximin page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン